Contact
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Bullous Pemphigoid (BP)
TO:
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Bullous Pemphigoid (BP)
TO: